Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.World Economyread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Asia Economyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Traderead more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
U.S. President Donald Trump's national security advisor said on Sunday that White House Asia policy adviser Matt Pottinger would become his top deputy.Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
Check out which companies are making headlines before the bell:
Tyson Foods – The food producer earned an adjusted $1.28 per share for its latest quarter, 10 cents A share above estimates. Revenue also exceeded forecasts as the company's beef and pork segments performed well.
Horizon Pharma – The drugmaker reported adjusted quarterly profit of 41 cents per share, well above the 10-cent-a-share consensus estimate. Revenue was also well above forecasts, boosted by a 70 percent jump in sales of Horizon's rare disease medicines.
UnitedHealth Group – The health insurer has named former GlaxoSmithKline CEO Andrew Witty and Morehouse School of Medicine President Valerie Montgomery Rice to its board of directors.
Berkshire Hathaway – Berkshire reported a 15 percent decline in second-quarter profit, falling below analysts' forecasts. The decline was led by smaller investment gains and insurance underwriting losses.
Deutsche Bank – Deutsche Bank fell out of a newly compiled list of the world's top 15 private banks. The 2016 rankings – put together by wealth management researcher Scorpio Partnership – showed private banking assets at Deutsche Bank were down 28 percent last year, pushing it down five places to number 16 on that list.
Tesla – Tesla lowered the price of its Model X SUV by $3,000 to $79,500, noting improved profit margins on that vehicle. Separately, the electric car maker announced its intention to sell $1.5 billion in a debt offering, in order to bolster its balance sheet while it tries to rapidly scale up production of its Model 3.
General Motors – GM is recalling nearly 800,000 pickup trucks to deal with an issue that could affect power steering. The affected models are 2014 Chevrolet Silverado 1500 and GMC Sierra 1500 trucks.
Apple – Apple will release a version of the Apple watch later this year that can directly make calls on cellular networks, according to a Bloomberg report. Current versions of the watch need to be connected to an iPhone to have cellular capability.
Sprint – The wireless carrier has resumed discussions T-Mobile US about a possible merger, according to a Bloomberg report. Masayoshi Son – the billionaire who leads major Sprint shareholder Softbank – is said to be seeking consolidation to reverse customer losses.
Chemours – The DuPont spin-off was upgraded to "neutral" from "sell" at UBS, which said it is more confident in the chemical maker's growth outlook following its recent quarterly results. UBS raised its price target on the stock to $50 from $36.